Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Operating Expenses | 44 | 60 | 30 | 49 | 33 |
| Operating Income | -44 | -60 | -30 | -49 | -33 |
| Other Income | 1 | 1 | 3 | 3 | 1 |
| Pre-tax Income | -43 | -59 | -27 | -46 | -32 |
| Net Income Continuous | -43 | -59 | -27 | -46 | -32 |
| Net Income | $-43 | $-59 | $-27 | $-46 | $-32 |
| EPS Basic Total Ops | -1.00 | -2.00 | -1.00 | -2.00 | -1.00 |
| EPS Basic Continuous Ops | -1.49 | -2.01 | -0.92 | -1.58 | -1.11 |
| EPS Diluted Total Ops | -1.00 | -2.00 | -1.00 | -2.00 | -1.00 |
| EPS Diluted Continuous Ops | -1.49 | -2.01 | -0.92 | -1.58 | -1.11 |
| EBITDA(a) | $-44 | $-60 | $-30 | $-49 | $-33 |